Mariette X, Criswell LA. Primary Sjögren’s syndrome. N Engl J Med. 2018;378(10):931–9.

Article  PubMed  Google Scholar 

Goules AV, Kapsogeorgou EK, Tzioufas AG. Insight into pathogenesis of Sjögren’s syndrome: dissection on autoimmune infiltrates and epithelial cells. Clin Immunol. 2017;182:30–40.

Article  CAS  PubMed  Google Scholar 

Ambrosi A, Wahren-Herlenius M. Update on the immunobiology of Sjögren’s syndrome. Curr Opin Rheumatol. 2015;27(5):468–75.

Article  CAS  PubMed  Google Scholar 

Bodewes ILA, Björk A, Versnel MA, Wahren-Herlenius M. Innate immunity and interferons in the pathogenesis of Sjögren’s syndrome. Rheumatology (Oxford). 2021;60(6):2561–73.

Article  CAS  PubMed  Google Scholar 

Shimizu T, Nakamura H, Takatani A, Umeda M, Horai Y, Kurushima S, Michitsuji T, Nakashima Y, Kawakami A. Activation of toll-like receptor 7 signaling in labial salivary glands of primary Sjögren’s syndrome patients. Clin Exp Immunol. 2019;196(1):39–51.

Article  CAS  PubMed  Google Scholar 

Fitzgerald KA, Kagan JC. Toll-like receptors and the control of immunity. Cell. 2020;180(6):1044–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Roussel-Queval A, Chasson L, Hanna Kazazian N, Marcadet L, Nezos A, Sieweke MH, Mavragani C, Alexopoulou L. TLR7 Signaling drives the development of Sjögren’s syndrome. Front Immunol. 2021;12:676010.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown GJ, Cañete PF, Wang H, Medhavy A, Bones J, Roco JA, He Y, Qin Y, Cappello J, Ellyard JI, et al. TLR7 gain-of-function genetic variation causes human lupus. Nature. 2022;605(7909):349–56.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Fillatreau S, Manfroi B, Dörner T. Toll-like receptor signalling in B cells during systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(2):98–108.

Article  CAS  PubMed  Google Scholar 

Teruel M, Alarcón-Riquelme ME. Genetics of systemic lupus erythematosus and Sjögren’s syndrome: an update. Curr Opin Rheumatol. 2016;28(5):506–14.

Article  CAS  PubMed  Google Scholar 

Soret P, Le Dantec C, Desvaux E, Foulquier N, Chassagnol B, Hubert S, Jamin C, Barturen G, Desachy G, Devauchelle-Pensec V, et al. A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome. Nat Commun. 2021;12(1):3523.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Trutschel D, Bost P, Mariette X, Bondet V, Llibre A, Posseme C, Charbit B, Thorball CW, Jonsson R, Lessard CJ, et al. Variability of primary Sjögren’s syndrome is driven by Interferon-α and Interferon-α blood levels are Associated with the class II HLA-DQ locus. Arthritis Rheumatol. 2022;74(12):1991–2002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, et al. 2016 American College of Rheumatology/European League against Rheumatism Classification Criteria for Primary Sjögren’s syndrome: a Consensus and Data-Driven Methodology Involving Three International Patient cohorts. Arthritis Rheumatol. 2017;69(1):35–45.

Article  PubMed  Google Scholar 

Fisher BA, Jonsson R, Daniels T, Bombardieri M, Brown RM, Morgan P, Bombardieri S, Ng WF, Tzioufas AG, Vitali C, et al. Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren’s syndrome. Ann Rheum Dis. 2017;76(7):1161–8.

Article  PubMed  Google Scholar 

Carrillo-Ballesteros FJ, Palafox-Sánchez CA, Franco-Topete RA, Muñoz-Valle JF, Orozco-Barocio G, Martínez-Bonilla GE, Gómez-López CE, Marín-Rosales M, López-Villalobos EF, Luquin S, et al. Expression of BAFF and BAFF receptors in primary Sjögren’s syndrome patients with ectopic germinal center-like structures. Clin Exp Med. 2020;20(4):615–26.

Article  CAS  PubMed  Google Scholar 

Daniels TE, Cox D, Shiboski CH, Schiødt M, Wu A, Lanfranchi H, Umehara H, Zhao Y, Challacombe S, Lam MY, et al. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren’s syndrome among 1,726 registry participants. Arthritis Rheum. 2011;63(7):2021–30.

Article  PubMed  PubMed Central  Google Scholar 

Yao Y, Liu Z, Jallal B, Shen N, Rönnblom L. Type I interferons in Sjögren’s syndrome. Autoimmun Rev. 2013;12(5):558–66.

Article  CAS  PubMed  Google Scholar 

Thorlacius GE, Wahren-Herlenius M, Rönnblom L. An update on the role of type I interferons in systemic lupus erythematosus and Sjögren’s syndrome. Curr Opin Rheumatol. 2018;30(5):471–81.

Article  CAS  PubMed  Google Scholar 

Alexopoulou L. Nucleic acid-sensing toll-like receptors: important players in Sjögren’s syndrome. Front Immunol. 2022;13:980400.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiang M, Wang Y, Gao Z, Wang J, Chen Q, Sun Z, Liang J, Xu J. Exploring causal correlations between inflammatory cytokines and systemic lupus erythematosus: a mendelian randomization. Front Immunol. 2022;13:985729.

Article  CAS  PubMed  Google Scholar 

Luo Z, Su R, Wang W, Liang Y, Zeng X, Shereen MA, Bashir N, Zhang Q, Zhao L, Wu K, et al. EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production. PLoS Pathog. 2019;15(11):e1008142.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Felten R, Devauchelle-Pensec V, Seror R, Duffau P, Saadoun D, Hachulla E, Pierre Yves H, Salliot C, Perdriger A, Morel J, et al. Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial. Ann Rheum Dis. 2021;80(3):329–38.

Article  CAS  PubMed  Google Scholar 

Davies R, Sarkar I, Hammenfors D, Bergum B, Vogelsang P, Solberg SM, Gavasso S, Brun JG, Jonsson R, Appel S. Single cell based phosphorylation profiling identifies alterations in toll-like receptor 7 and 9 signaling in patients with primary Sjögren’s syndrome. Front Immunol. 2019;10:281.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Punnanitinont A, Kasperek EM, Kiripolsky J, Zhu C, Miecznikowski JC, Kramer JM. TLR7 agonism accelerates disease in a mouse model of primary Sjögren’s syndrome and drives expansion of T-bet(+) B cells. Front Immunol. 2022;13:1034336.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang ZH, Feng Y, Hu Q, Wang XL, Zhang L, Liu TT, Zhang JT, Yang X, Fu QY, Fu DN, et al. Keratinocyte TLR2 and TLR7 contribute to chronic itch through pruritic cytokines and chemokines in mice. J Cell Physiol. 2023;238(1):257–73.

Article  CAS  PubMed  Google Scholar 

Theander E, Jonsson R, Sjöström B, Brokstad K, Olsson P, Henriksson G. Prediction of Sjögren’s Syndrome years before diagnosis and identification of patients with early onset and severe Disease Course by Autoantibody Profiling. Arthritis Rheumatol. 2015;67(9):2427–36.

Article  CAS  PubMed  Google Scholar 

Jonsson R, Theander E, Sjöström B, Brokstad K, Henriksson G. Autoantibodies present before symptom onset in primary Sjögren syndrome. JAMA. 2013;310(17):1854–5.

Article  CAS  PubMed  Google Scholar 

Lopes AP, Hillen MR, Hinrichs AC, Blokland SL, Bekker CP, Pandit A, Kruize AA, Radstake TR, van Roon JA. Deciphering the role of cDC2s in Sjögren’s syndrome: transcriptomic profile links altered antigen processes with IFN signature and autoimmunity. Ann Rheum Dis. 2023;82(3):374–83.

Article  PubMed  Google Scholar